{
    "organizations": [],
    "uuid": "6ba85737a95c17e8c896771355524b52eb9b3c8a",
    "author": "cnbc.com",
    "url": "http://www.cnbc.com/2018/04/11/business-wire-cardiovascular-systems-inc-to-webcast-fiscal-2018-third-quarter-earnings-conference-call-wednesday-may-2.html",
    "ord_in_thread": 0,
    "title": "Cardiovascular Systems, Inc. to Webcast Fiscal 2018 Third-Quarter Earnings Conference Call Wednesday, May 2",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Live Webcast at 3:45 p.m. CT (4:45 p.m. ET)\nST. PAUL, Minn.--(BUSINESS WIRE)-- Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII) will host a live webcast of its fiscal 2018 third-quarter conference call on Wednesday, May 2, 2018, at 3:45 p.m. CT (4:45 p.m. ET). CSI management will discuss results for its fiscal third quarter ended March 31, 2018, and its financial outlook. The company will issue a post-market earnings release prior to the call on May 2.\nTo access the live webcast, go to the events section of the company’s investor relations website, https://investors.csi360.com/events-and-presentations/events-calendar/default.aspx , on the day of the conference, call and click on the webcast link. A webcast replay will be available beginning at 6:45 p.m. CT the same day.\nTo participate in the conference call, dial (833) 241-7255 and enter 5378729. Please dial in at least 10 minutes prior to the call.\nAbout Cardiovascular Systems, Inc.\nCardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company’s Orbital Atherectomy Systems treat calcified and fibrotic plaque in arterial vessels throughout the leg and heart in a few minutes of treatment time, and address many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives. The U.S. FDA granted the first 510(k) clearance for the use of the Orbital Atherectomy System in peripheral arteries in August 2007. In October 2013, the company received FDA approval for the Coronary Orbital Atherectomy System. To date, over 356,000 of CSI’s devices have been sold to leading institutions across the United States. For more information, visit the company’s website at www.csi360.com .\nView source version on businesswire.com : https://www.businesswire.com/news/home/20180411005837/en/\nCardiovascular Systems, Inc.\nJack Nielsen, 651-202-4919\nj.nielsen@csi360.com\nor\nPadilla\nMatt Sullivan, 612-455-1709\nmatt.sullivan@padillaco.com\nSource: Cardiovascular Systems, Inc.",
    "published": "2018-04-12T00:05:00.000+03:00",
    "crawled": "2018-04-12T00:22:41.001+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "live",
        "webcast",
        "ct",
        "et",
        "paul",
        "business",
        "wire",
        "cardiovascular",
        "system",
        "csi",
        "nasdaq",
        "csii",
        "host",
        "live",
        "webcast",
        "fiscal",
        "conference",
        "call",
        "wednesday",
        "may",
        "ct",
        "et",
        "csi",
        "management",
        "discus",
        "result",
        "fiscal",
        "third",
        "quarter",
        "ended",
        "march",
        "financial",
        "outlook",
        "company",
        "issue",
        "earnings",
        "release",
        "prior",
        "call",
        "may",
        "access",
        "live",
        "webcast",
        "go",
        "event",
        "section",
        "company",
        "investor",
        "relation",
        "website",
        "http",
        "day",
        "conference",
        "call",
        "click",
        "webcast",
        "link",
        "webcast",
        "replay",
        "available",
        "beginning",
        "ct",
        "day",
        "participate",
        "conference",
        "call",
        "dial",
        "enter",
        "please",
        "dial",
        "least",
        "minute",
        "prior",
        "call",
        "cardiovascular",
        "system",
        "cardiovascular",
        "system",
        "based",
        "paul",
        "medical",
        "device",
        "company",
        "focused",
        "developing",
        "commercializing",
        "innovative",
        "solution",
        "treating",
        "vascular",
        "coronary",
        "disease",
        "company",
        "orbital",
        "atherectomy",
        "system",
        "treat",
        "calcified",
        "fibrotic",
        "plaque",
        "arterial",
        "vessel",
        "throughout",
        "leg",
        "heart",
        "minute",
        "treatment",
        "time",
        "address",
        "many",
        "limitation",
        "associated",
        "existing",
        "surgical",
        "catheter",
        "pharmacological",
        "treatment",
        "alternative",
        "fda",
        "granted",
        "first",
        "k",
        "clearance",
        "use",
        "orbital",
        "atherectomy",
        "system",
        "peripheral",
        "artery",
        "august",
        "october",
        "company",
        "received",
        "fda",
        "approval",
        "coronary",
        "orbital",
        "atherectomy",
        "system",
        "date",
        "csi",
        "device",
        "sold",
        "leading",
        "institution",
        "across",
        "united",
        "state",
        "information",
        "visit",
        "company",
        "website",
        "view",
        "source",
        "version",
        "http",
        "cardiovascular",
        "system",
        "jack",
        "nielsen",
        "padilla",
        "matt",
        "sullivan",
        "source",
        "cardiovascular",
        "system",
        "inc"
    ]
}